Drugs / Influenza Vaccine (Surface Antigen, Inactivated)
last change Aug 2008 re-read 3 minutes ago

Influenza Vaccine (Surface Antigen, Inactivated)

also known as Flu Vaccine

Vaccine

Developed for
influenza
Investigated by
Novartis Vaccines

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00748150 Jul → Aug 2008 influenza Novartis Vaccines Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Influenza Vaccine (Surface Antigen, Inactivated) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00748150 ↗
Known as Flu Vaccine “Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009” NCT00748150 ↗
Modality Vaccine “influenza vaccine” NCT00748150 ↗